Lupus News

Many drugs can induce cutaneous or systemic lupus erythematosus, and physicians should be aware of the evolving drug association list, according to a study.

A 2-year randomized controlled trial has found that belimumab plus standard therapy is superior to standard therapy alone in patients with lupus nephritis, according to data published in the New England Journal of Medicine.

When it comes to studying treatments for systemic lupus erythematosus, issues such as clinical trial design and patient selection still loom large, according to a speaker at the 2020 Congress of Clinical Rheumatology-East.

It is essential that rheumatologists aim for “low” or “quiescent” disease activity several months before conception in their patients who desire to become pregnant, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

Understanding the intersections of race, gender and molecular factors is critical to understanding lupus disease phenotypes, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

Depression symptoms were associated with unemployment among working-age adults with arthritis, with middle-aged adults most affected, according to data published in Arthritis Care & Research.

Hydroxychloroquine was not associated with either benefit or harm regarding COVID-19 mortality, and the evidence supporting the effect of other antirheumatic therapies is inconclusive, noted data published in Arthritis & Rheumatology.

Patients with immune checkpoint therapy-induced inflammatory arthritis report significant social, functional and emotional impacts, compared with cancer and other side effects, according to findings published in BMC Rheumatology.

Prescription immunosuppressant use is low during the first year of care among young patients with newly diagnosed systemic lupus erythematosus, while hydroxychloroquine use is prevalent, although not universal, researchers report.

Patients with systemic lupus erythematosus are more likely than those in the general population to skip doses, take less medicine and delay filling prescriptions due to cost, according to data published in Arthritis Care & Research.